Stay updated on Durvalumab Combo in Advanced Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Advanced Liver Cancer Clinical Trial page.

Latest updates to the Durvalumab Combo in Advanced Liver Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision label on the page updated to v3.6.3, replacing v3.6.2, indicating a new version of the page content.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page now displays Revision: v3.6.2 in place of the previous Revision: v3.6.0. This reflects a routine site revision rather than a change to the study data or content.SummaryDifference0.0%

- Check33 days agoChange DetectedNew navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label was reformatted. The recruitment status now indicates No longer looking for participants, with updates to the study citation and revision metadata.SummaryDifference0.2%

- Check40 days agoChange DetectedA new page revision tag was added (v3.5.5), signaling a back-end update to the ClinicalTrials.gov page; the study details and user-facing content remain unchanged.SummaryDifference0.0%

- Check61 days agoChange DetectedA new publication citation for the HIMALAYA five-year survival update was added, and the page revision tag updated from v3.5.3 to v3.5.4.SummaryDifference0.0%

- Check68 days agoChange DetectedThe Taiwan recruitment locations were updated: Taoyuan District, Taiwan was removed and Taoyuan, Taiwan was added.SummaryDifference0.0%

Stay in the know with updates to Durvalumab Combo in Advanced Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Advanced Liver Cancer Clinical Trial page.